Lung cancer
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with radiologically detected pulmonary nodules meeting size requirements who provide informed consent; 2.Individuals with histologically confirmed benign or malignant pulmonary nodules (via recent surgery/biopsy); 3.Subjects without severe comorbidities or immune disorders that may confound study outcomes;
Exclusion criteria
Exclusion criteria: 1.History of concurrent malignancies; 2.Severe impairment of cardiac, hepatic, renal, or other vital organ functions potentially interfering with assessment; 3.Immunodeficiency disorders or active chemo/radiotherapy recipients where metabolic/transcriptional profiles may be altered; 4.Declined participation or inability to comply with study procedures and follow-up;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pathological Examination; | — |
Secondary
| Measure | Time frame |
|---|---|
| Spatial Transcriptomics;Untargeted Metabolomics; | — |
Countries
China
Contacts
Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)